CoChat

Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage

Open access

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

Phages and cancer immunity Gut bacteria are involved in the education of T cell immune responses, and the intestinal ecosystem influences anticancer immunity. Fluckiger et al. report microbial antigens that might cross-react with antigens associated with tumor cells. They found that a type of intestinal bacteria called enterococci harbor a bacteriophage that modulates immune responses. In mouse models, administration of enterococci containing the bacteriophage boosted T cell responses after treatment with chemotherapy or programmed cell death protein 1 (PD-1) blockade. In humans, the presence of the bacteriophage was associated with improved survival after PD-1 immunotherapy. A fraction of human T cells specific for naturally processed melanoma epitopes appeared to be able to recognize microbial peptides. This “molecular mimicry” may represent cross-reactivity between tumors and microbial antigens. Science , this issue p. 936

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.aax0701

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

6 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 402

Metadata

Authors
Fluckiger, A., Daillère, R., Sassi, M., Sixt, B. S., Liu, P., Loos, F., Richard, C., Rabu, C., Alou, M. T., Goubet, A.-G., Lemaitre, F., Ferrere, G., Derosa, L., Duong, C. P. M., Messaoudene, M., Gagné, A., Joubert, P., De Sordi, L., Debarbieux, L., Simon, S., Scarlata, C.-M., Ayyoub, M., Palermo, B., Facciolo, F., Boidot, R., Wheeler, R., Boneca, I. G., Sztupinszki, Z., Papp, K., Csabai, I., Pasolli, E., Segata, N., Lopez-Otin, C., Szallasi, Z., Andre, F., Iebba, V., Quiniou, V., Klatzmann, D., Boukhalil, J., Khelaifia, S., Raoult, D., Albiges, L., Escudier, B., Eggermont, A., Mami-Chouaib, F., Nistico, P., Ghiringhelli, F., Routy, B., Labarrière, N., Cattoir, V., Kroemer, G., & Zitvogel, L.
Affiliations
  • Inserm (FR)
  • Université de Bourgogne (FR)
  • Gustave Roussy Cancer Campus (GRCC), Villejuif, France.
  • Institut universitaire de cardiologie et de pneumologie de Québec (CA)
  • Bacteriophage, Bacterium, Host Laboratory, Institut Pasteur, F-75015 Paris, France.
  • Institut Pasteur (FR)
  • Université Toulouse III - Paul Sabatier (FR)
  • Instituto Nazionale Tumori Regina Elena (IT)
  • Centre Georges François Leclerc (FR)
  • Computational Health Informatics Program (CHIP), Boston Children's Hospital, Boston, MA, USA.
  • Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Budapest, Hungary.
  • University of Naples Federico II (IT)
  • University of Trento (IT)
  • Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France.
  • Department of Cancer Medicine, Breast Cancer Committee, Gustave Roussy, Villejuif, France.
  • University of Trieste (IT)
  • UMR MEPHI, Aix-Marseille Université, IRD, AP-HM, Institut Hospitalo-Universitaire Méditerranée-Infection, 19-21 Boulevard Jean Moulin, 13385, Marseille cedex 05, France.
  • Aix-Marseille Université (FR)
  • Institut Gustave Roussy (FR)
  • INSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Fac. de Médecine - Univ. Paris-Sud, Université Paris-Saclay, 94805, Villejuif, France.
  • Unit of Tumor Immunology and Immunotherapy, Department of Research, Advanced Diagnostics and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Karolinska University Hospital (SE)
Corresponding author
  • Kroemer, Guido
  • Zitvogel, Laurence
Venue
Science
Published
2020-08-21
Volume
369
Issue
6506
Pages
936-942
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W3081393016
Cited by
396
References
53
Citations by year
2026: 47 · 2025: 77 · 2024: 59 · 2023: 80 · 2022: 61 · 2021: 62 · 2020: 9
FWCI
18.57
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Science (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
  • ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, other-oa)
  • Institutional Research Information System (Università degli Studi di Trento) (submittedVersion)
Funders
Agence Nationale de la Recherche (ANR-10-LABX-0015, ANR-19-CE15-0029, ANR-16-RHUS-0008)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions
Keywords
bacteriophages, Enterococcus, cross-reactivity, molecular mimicry, tumor antigens, T cell response, gut microbiota, cancer immunotherapy, anti-PD-1 therapy, chemotherapy, microbial peptides, immune checkpoint inhibitors
MeSH terms
Gastrointestinal Microbiome, Enterococcus hirae, Animals, Antibodies, Monoclonal, Epitopes, Antigens, Neoplasm, Bacteriophages, Cross Reactions, Cyclophosphamide, Feces, H-2 Antigens, Humans, Immunotherapy, Neoplasms, Histocompatibility Antigens Class I, Viral Tail Proteins, CD8-Positive T-Lymphocytes, Antineoplastic Agents, Alkylating, Mice, Programmed Cell Death 1 Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.